rs12324292

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000814.6(GABRB3):​c.240+14468G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.337 in 152,008 control chromosomes in the GnomAD database, including 9,141 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.34 ( 9141 hom., cov: 32)

Consequence

GABRB3
NM_000814.6 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.0980

Publications

6 publications found
Variant links:
Genes affected
GABRB3 (HGNC:4083): (gamma-aminobutyric acid type A receptor subunit beta3) This gene encodes a member of the ligand-gated ionic channel family. The encoded protein is one the subunits of a multi-subunit chloride channel that serves as the receptor for gamma-aminobutyric acid, a major inhibitory neurotransmitter of the mammalian nervous system. This gene is located on the long arm of chromosome 15 in a cluster with two other genes encoding related subunits of the family. This gene may be associated with the pathogenesis of several disorders including Angelman syndrome, Prader-Willi syndrome, nonsyndromic orofacial clefts, epilepsy and autism. Alternatively spliced transcript variants encoding distinct isoforms have been described. [provided by RefSeq, Jul 2013]
GABRB3 Gene-Disease associations (from GenCC):
  • developmental and epileptic encephalopathy, 43
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • epilepsy, childhood absence, susceptibility to, 5
    Inheritance: AD, Unknown Classification: DEFINITIVE, LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • genetic developmental and epileptic encephalopathy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • childhood absence epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Lennox-Gastaut syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.436 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000814.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GABRB3
NM_000814.6
MANE Select
c.240+14468G>A
intron
N/ANP_000805.1
GABRB3
NM_021912.5
c.240+14468G>A
intron
N/ANP_068712.1
GABRB3
NM_001278631.2
c.-112+14468G>A
intron
N/ANP_001265560.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GABRB3
ENST00000311550.10
TSL:1 MANE Select
c.240+14468G>A
intron
N/AENSP00000308725.5
GABRB3
ENST00000541819.6
TSL:1
c.408+14468G>A
intron
N/AENSP00000442408.2
GABRB3
ENST00000299267.9
TSL:1
c.240+14468G>A
intron
N/AENSP00000299267.4

Frequencies

GnomAD3 genomes
AF:
0.336
AC:
51101
AN:
151890
Hom.:
9115
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.441
Gnomad AMI
AF:
0.312
Gnomad AMR
AF:
0.234
Gnomad ASJ
AF:
0.288
Gnomad EAS
AF:
0.128
Gnomad SAS
AF:
0.287
Gnomad FIN
AF:
0.368
Gnomad MID
AF:
0.310
Gnomad NFE
AF:
0.314
Gnomad OTH
AF:
0.318
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.337
AC:
51169
AN:
152008
Hom.:
9141
Cov.:
32
AF XY:
0.334
AC XY:
24849
AN XY:
74320
show subpopulations
African (AFR)
AF:
0.441
AC:
18296
AN:
41454
American (AMR)
AF:
0.234
AC:
3571
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.288
AC:
999
AN:
3468
East Asian (EAS)
AF:
0.127
AC:
659
AN:
5176
South Asian (SAS)
AF:
0.289
AC:
1393
AN:
4816
European-Finnish (FIN)
AF:
0.368
AC:
3872
AN:
10524
Middle Eastern (MID)
AF:
0.310
AC:
91
AN:
294
European-Non Finnish (NFE)
AF:
0.314
AC:
21338
AN:
67974
Other (OTH)
AF:
0.316
AC:
667
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1659
3319
4978
6638
8297
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
506
1012
1518
2024
2530
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.313
Hom.:
13321
Bravo
AF:
0.329
Asia WGS
AF:
0.191
AC:
660
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
3.6
DANN
Benign
0.75
PhyloP100
0.098
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12324292; hg19: chr15-27003081; API